P898 - VITAMIN B COMPLEX INTAKE IN YOUNG ADULTS AT RISK AND WITH METABOLIC SYNDROME

P898

VITAMIN B COMPLEX INTAKE IN YOUNG ADULTS AT RISK AND WITH METABOLIC SYNDROME

R. Herrera Saucedo^1,*, B. G. Baez Duarte¹, I. Z. Ginez¹, M. D. L. C. Martínez Montaño²

¹Metabologenómica, ²Laboratorio de Investigación en Bioquímica, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico

Rationale: Metabolic syndrome (MS) is a group of metabolic disorders, which together with inadequate dietary patterns increase this risk of developing cardiovascular diseases in young adults, so the aim of the study is to analyze the intake of vitamins B complex in healthy young adults at risk of MS and with MS.

Methods: A comparative cross-sectional study was carried out in subjects of both sexes from 18 to 26 years old, who agreed to participate voluntarily. MS was determined according to NCEP-ATP III criteria adjusted for the Mexican population. Diagnosis was established if three or more of the following criteria were present: blood pressure (BP) ≥130/85 mmHg, fasting glucose ≥100 mg/dL, TG ≥150 mg/dL, HDL-c ≤40 mg/dL in men and ≤50 mg/dL in women, and waist circumference (WC) ≥90 in men and ≥80 cm in women. Dietary intake of vitamins was assessed using three 24-hour recalls (two during the week and one on weekend). Variables were compared between the healthy young adult’s groups (without any MS criteria), at-risk (with one or two MS criteria), and with MS using the Kruskal-Wallis test. 

Results: 90 subjects participated, of which 40% were women and 60% men, the average age was 20.11±2.3 years. It was found that 21 subjects were healthy, 61 had one or two MS criteria and 8 with MS; in the comparative analysis of the intake of vitamins B complex between these study groups, significant differences were observed in thiamine (B1)(1.6 mg, 1.3 mg and 1.2 mg, p=0.05, respectively); riboflavin (B2)(1.9 mg, 1.7 mg and 1.25. p=0.013, respectively); niacin (B3)(48.9 mg, 36.4 mg and 25.15 mg, p=0.045, respectively); pyridoxine (B6)(2.8 mg, 1.6 mg and 1.15 mg, p=0.023, respectively) and no significant differences in cyanocobalamin (B12)(3.8 mg, 3.6 mg and 3.05 mg, p=0.182, respectively).

Conclusion: The results indicate a pattern of lower dietary intake of vitamins B in subjects at risk and with MS, compared to the healthy subject’s group.

Disclosure of Interest: None declared